OJGas  Vol.5 No.6 , June 2015
Role of Serum Zinc Level and P300 Event Related Potential in Detection of Minimal Hepatic Encephalopathy
ABSTRACT
Background: Minimal hepatic encephalopathy (MHE) is defined as hepatic encephalopathy (HE) without symptoms on clinical/neurological examination, but with deficits in some cognitive areas that can only be measured by neuropsychometric testing. Aim: Our aim was to study serum zinc levels in cirrhotic patients with and without MHE and correlate it with the results of neuropsychological tests and P300 event related potential. Patients and Methods: Fifty-five patients with liver cirrhosis were recruited for the present study. All patients were subjected to full history taking, clinical examination, abdominal ultrasonography, laboratory investigations including liver function tests and serum zinc, psychometric studies (line tracing test and serial dotting test) and P300 event related potential. According to the results of psychometric studies and P300 event related potential, the patients were divided into 3 groups in addition to the control group. Results: Among the 55 patients included in the study, 30 patients had no clinical evidence of HE and 25 patients had overt HE with different grades. In patients with no clinical evidence of HE, psychometric tests and P300 event related potential revealed that 13 patients had MHE, while 17 had no HE. There were significantly lower serum zinc levels in patients with MHE and in cirrhotic patients without HE compared with the healthy controls. Also, zinc levels were significantly lower in higher grades of hepatic encephalopathy. Serum zinc levels showed positive correlation with serum albumin levels and inverse correlation with serial dotting test and P300 latency. Conclusion: Reduced serum zinc level and prolonged P300 latency can serve as predictors of minimal hepatic encephalopathy in cirrhotic patients. Zinc deficiency is common in cirrhotic patients with MHE. These findings may have important prognostic and therapeutic implications in MHE and overt HE patients with zinc deficiency.

Cite this paper
Galal, G. , Saif-Al-Islam, M. , Abd Al Rahman, M. , Ahmed, N. and Abd El Rhman, M. (2015) Role of Serum Zinc Level and P300 Event Related Potential in Detection of Minimal Hepatic Encephalopathy. Open Journal of Gastroenterology, 5, 58-65. doi: 10.4236/ojgas.2015.56011.
References
[1]   Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K. and Blei, A.T. (2002) Hepatic Encephalopathy-Definition, Nomenclature, Diagnosis, and Quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35, 716-721.
http://dx.doi.org/10.1053/jhep.2002.31250

[2]   Dhiman, R.K., Saraswat, V.A., Sharma, B.K., Sarin, S.K., Chawla, Y.K. and Butterworth, R. (2010) Minimal Hepatic Encephalopathy: Consensus Statement of a Working Party of the Indian National Association for Study of the Liver. Journal of Gastroenterology and Hepatology, 25, 1029-1041.
http://dx.doi.org/10.1111/j.1440-1746.2010.06318.x

[3]   Sarin, S.K. and Nundy, S. (1985) Subclinical Encephalopathy after Portosystemic Shunts in Patients with Non-Cirrhotic Portal Fibrosis. Liver, 5, 142-146.
http://dx.doi.org/10.1111/j.1600-0676.1985.tb00229.x

[4]   Bajaj, J.S., Hafeezullah, M., Hoffmann, R.G. and Saeian, K. (2007) Minimal Hepatic Encephalopathy: A Vehicle for Accidents and Traffic Violations. American Journal of Gastroenterology, 102, 1903-1909.
http://dx.doi.org/10.1111/j.1572-0241.2007.01424.x

[5]   Schomerus, H. and Hamster, W. (2001) Quality of Life in Cirrhotics with Minimal Hepatic Encephalopathy. Metabolic Brain Disease, 16, 37-41.
http://dx.doi.org/10.1023/A:1011610427843

[6]   Bajaj, J.S., Hafeezullah, M., Hoffmann, R.G., Varma, R.R., Franco, J., Binion, D.G., Hammeke, T.A. and Saeian, K. (2008) Navigation Skill Impairment: Another Dimension of the Driving Difficulties in Minimal Hepatic Encephalopathy. Hepatology, 47, 596-604.
http://dx.doi.org/10.1002/hep.22032

[7]   Sunil, H.V., Mittal, B.R., Kumi, R., Chawla, Y.K. and Dhiman, R.K. (2012) Brain Perfusion Single Photon Emission Computed Tomography (SPECT) Abnormalities in Patients with Minimal Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology, 2, 116-121.
http://dx.doi.org/10.1016/S0973-6883(12)60099-1

[8]   Panickar, K.S., Jayakumar, A.R., Rao, K.V. and Norenberg, M.D. (2009) Ammonia-Induced Activation of p53 in Cultured Astrocytes: Role in Cell Swelling and Glutamate Uptake. Neurochemistry International, 55, 98-105.
http://dx.doi.org/10.1016/j.neuint.2008.12.022

[9]   Rabbani, P. and Prasad, A. (1978) Plasma Ammonia and Liver Ornithine Transcarbamoylase Activity in Zinc-Deficient Rats. American Journal of Physiology, 235, 203-206.

[10]   Gorg, B., Qvartskhava, N. and Bidmon, H.J. (2010) Oxidative Stress Markers in the Brain of Patients with Cirrhosis and Hepatic Encephalopathy. Hepatology, 52, 256-265.
http://dx.doi.org/10.1002/hep.23656

[11]   Al Amin, H. and Saad, A. (2009) Subclinical Hepatic Encephalopathy: The Role of Neuropsychological and Electrophysiological Tools in Diagnosis. Current Psychiatry, 16, 215-222.

[12]   Farid, M.N., El Sayed, N. and Essawy, H. (2000) Auditory P300 Event-Related Potential in Detection of Subclinical Hepatic Encephalopathy in Children. Current Psychiatry, 7, 199-213.

[13]   Pugh, R., Murray-Lyon, I. and Dawson, J. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. The British Journal of Surgery, 60, 646-649.
http://dx.doi.org/10.1002/bjs.1800600817

[14]   Ramzy, M., Dos, W., Mokhtar, S., Abdd Hafez, H., Abd El Kade, A., El Gohary, A., Obia, I. and Mahmoud, A. (2008) Serum Zinc Level as a Predictor of Suhclinical Hepatic Encephalopathy in Patients with Liver Cirrhosis. Arabian Journal Gastroentrology, 9, 101-105.

[15]   Saxena, N., Bhatia, M., Joshi, Y.K., Garg, P.K., Dwivedi, S.N. and Tandon, R.K. (2002) Electrophysiological and Neuropsychological Tests for Diagnosis of Subclinical Hepatic Encephalopathy and Prediction of Overt Encephalopathy. Liver, 22, 190-197.
http://dx.doi.org/10.1034/j.1600-0676.2002.01431.x

[16]   Weissenborn, K., Scholz, M., Lautz, H.U., Schmidt, F.W. and Kunkel, H. (1990) Diagnostic and Prognostic Value of P300 Examination in Patients with Early Hepatic Encephalopathy. Journal of Hepatology, 10, S25.

[17]   Gallai, V., Alberti, A., Balo, S., Mazzotta, G., Clerici, C., Gentili, G., Firenze, C. and Morelli, A. (1995) Cognitive Event-Related Potential in Hepatic Encephalopathy. Acta Neurologica Scandinavica, 91, 358-361.
http://dx.doi.org/10.1111/j.1600-0404.1995.tb07021.x

[18]   Davies, M.G., Rowan, M.J., MacMathina, P., Keeling, P.W.N., Weir, D.G. and Feely, J. (1990) The Auditory P300 Event Related Potential: An Objective Marker of the Encephalopathy of Chronic Liver Disease. Hepatology, 12, 688-694.
http://dx.doi.org/10.1002/hep.1840120412

[19]   McClain, C.J., Marsano, L., Burk, R.F. and Bacon, B. (1991) Trace Metals in Liver Disease. Seminars in Liver Disease, 11, 321-339.
http://dx.doi.org/10.1055/s-2008-1040450

[20]   Rahelic, D., Kujundzic, M., Romic, Z., Brkic, K. and Petrovecki, M. (2006) Serum Concentration of Zinc, Copper, Manganese and Magnesium in Patients with Liver Cirrhosis. Collegium Antropologicum, 30, 523-528.

[21]   Yang, S.S., Lai, Y.C., Chiang, T.R., Chen, D.F. and Chen, D.S. (2004) Role of Zinc in Subclinical Hepatic Encephalopathy: Comparison with Somatosensory-Evoked Potentials. Journal of Gastroenterology and Hepatology, 19, 375-379.
http://dx.doi.org/10.1111/j.1440-1746.2003.03281.x

[22]   Kugelmas, M. (2000) Preliminary Observation: Oral Zinc Sulfate Replacement Is Effective in Treating Muscle Cramps in Cirrhotic Patients. Journal of the American College of Nutrition, 19, 13-15.
http://dx.doi.org/10.1080/07315724.2000.10718908

[23]   Frederickson, C.J., Suh, S.W., Silva, D., Frederickson, C.J. and Thompson, R.B. (2000) Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron. Journal of Nutrition, 130, 1471-1483.

[24]   Chetri, K. and Choudhuri, G. (2003) Role of Trace Elements in Hepatic Encephalopathy: Zinc and Manganese. Indian Journal of Gastroenterology, 22, 28-30.

[25]   Loomba, V., Pawar, G., Dhar, K.L. and Setia, M.S. (1995) Serum Zinc Levels in Hepatic Encephalopathy. Indian Journal of Gastroenterology, 14, 51-53.

[26]   Moriyama, M., Matsumura, H., Fukushima, A., Ohkido, K., Arakawa, Y., Nirei, K., Yamagami, H., Kaneko, M., Tanaka, N. and Arakawa, Y. (2006) Clinical Significance of Evaluation of Serum Zinc Concentrations in C-Viral Chronic Liver Disease. Digestive Disease and Science, 51, 1967-1977.
http://dx.doi.org/10.1007/s10620-005-9051-7

[27]   Zeng, Z., Li, Y.Y. and Nio, Y.Q. (2003) An Epidemiological Survey of Subclinical Hepatic Encephalopathy. Chinese Journal of Hepatology, 1, 680-682.

 
 
Top